Grifols SA ADR

GRFS · Moat type: REGULIERUNG

MoatScore

3/10

Fair Value

6 USD

Margin of Safety

-22.6 %

Rating

SCHWACH

GESCHÄFTSMODELL Grifols SA is a Spanish biopharmaceutical company that manufactures proteins derived from human blood plasma (immunoglobulins, albumin, coagulation factors) and distributes them worldwide to hospitals and clinics.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.